File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Could SGLT2 inhibitors be the next ‘game changer’ in focal segmental glomerulosclerosis?

TitleCould SGLT2 inhibitors be the next ‘game changer’ in focal segmental glomerulosclerosis?
Authors
Chan, Anthony T PTang, Sydney C W
Keywordsfocal segmental glomerulosclerosis
nondiabetic CKD
podocytopathy
SGLT2 inhibitor
Issue Date1-Sep-2022
PublisherOxford University Press
Citation
Nephrology Dialysis Transplantation, 2022, v. 37, n. 9, p. 1593-1594 How to Cite?
DOI: http://dx.doi.org/10.1093/ndt/gfac139
Persistent Identifierhttp://hdl.handle.net/10722/338816
ISSN
0931-0509
2023 Impact Factor: 4.8
2023 SCImago Journal Rankings: 1.414
ISI Accession Number ID
WOS:000796711900001

 

DC FieldValueLanguage
dc.contributor.authorChan, Anthony T P-
dc.contributor.authorTang, Sydney C W-
dc.date.accessioned2024-03-11T10:31:46Z-
dc.date.available2024-03-11T10:31:46Z-
dc.date.issued2022-09-01-
dc.identifier.citationNephrology Dialysis Transplantation, 2022, v. 37, n. 9, p. 1593-1594-
dc.identifier.issn0931-0509-
dc.identifier.urihttp://hdl.handle.net/10722/338816-
dc.languageeng-
dc.publisherOxford University Press-
dc.relation.ispartofNephrology Dialysis Transplantation-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.subjectfocal segmental glomerulosclerosis-
dc.subjectnondiabetic CKD-
dc.subjectpodocytopathy-
dc.subjectSGLT2 inhibitor-
dc.titleCould SGLT2 inhibitors be the next ‘game changer’ in focal segmental glomerulosclerosis?-
dc.typeArticle-
dc.identifier.doi10.1093/ndt/gfac139-
dc.identifier.scopuseid_2-s2.0-85137008185-
dc.identifier.volume37-
dc.identifier.issue9-
dc.identifier.spage1593-
dc.identifier.epage1594-
dc.identifier.eissn1460-2385-
dc.identifier.isiWOS:000796711900001-
dc.identifier.issnl0931-0509-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats